National Bank of Canada
IDYA icon

National Bank of Canada’s IDEAYA Biosciences IDYA Stock Holding History

National Bank of Canada’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.21K Buy
113
+89
+371% +$2.72K ﹤0.01% 2586
2026
Q1 		$799 Buy
+24
New +$805 ﹤0.01% 2699

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

National Bank of Canada's IDYA Position: Q2 2026 in Review

National Bank of Canada increased its IDEAYA Biosciences (IDYA) stake by 371% in Q2 2026, buying an estimated $2.72K and bringing the position to 113 shares worth $4.21K. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

National Bank of Canada first reported a position in IDYA in Q1 2026 and has held it in 2 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • National Bank of Canada held 113 shares of IDEAYA Biosciences worth $4.21K as of Q2 2026.
  • National Bank of Canada bought 89 IDEAYA Biosciences shares in Q2 2026, an estimated $2.72K.
  • IDEAYA Biosciences made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2586 holding.
  • National Bank of Canada first reported a position in IDEAYA Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.